R&D Systems™ Recombinant Human BTLA Fc Chimera (aa 31-153) Protein

Catalog No.	Quantity
95-09B-T100	100 μg

Catalog No. 95-09B-T100 Supplier R&D Systems™ Supplier No. 9509BT100

Description

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.

Measured by its binding ability in a functional ELISA. When Recombinant Mouse HVEM/TNFRSF14 Fc Chimera (Catalog # 2516-HV ) is immobilized at 0.5 μg/mL, 100 μL/well, the concentration of Recombinant Human BTLA Fc Chimera that produces 50% of the optimal binding response is 15-90 ng/mL.

Specifications

• Accession Number: Q7Z6A9-1
• Characterization: Bioactivity
• For Use With (Application): Bioactivity
• Formulation: Lyophilized from a 0.2 μm filtered solution in PBS.
• Gene ID (Entrez): 151888
• Molecular Weight (g/mol): M.W. (Observed): 52-61 kDa, reducing conditions; M.W. (theoretical): 41 kDa
• Quantity: 100 μg
• Source: Human embryonic kidney cell, HEK293-derived human BTLA protein Human BTLA (Lys31-Trp153) (N-terminus) Accession # Q7Z6A9-1 IEGRMD Human IgG1 (Pro100-Lys330) (C-terminus)
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20°C to -70°C as supplied. 1 month, 2°C to 8°C under sterile conditions after reconstitution. 3 months, -20°C to -70°C under sterile conditions after reconstitution.
• Endotoxin Concentration: <0.10 EU / 1 μg of the protein by the LAL method.
• Gene Alias: B and T lymphocyte associated, B and T lymphocyte attenuator, B- and T-lymphocyte attenuator, B- and T-lymphocyte-associated protein, BTLA1, CD272, CD272 antigen, FLJ16065,mgC129743
• Product Type: Recombinant Protein
• Conjugate: Unconjugated
• Species: Human
• Reconstitution: Reconstitute at 500 μg/mL in PBS.
• Purity or Quality Grade: >95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining.
• Protein: BTLA/CD272